{"transactions":[{"id":2414346,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":130826,"kind":"person","name":"Zimmermann Carolyne","position":1,"cik":"0001860163","reported_name":"Zimmermann Carolyne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-03T17:42:54.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 1, 2022 (the \"Vesting Commencement Date\") while the grantee remains a service provider to the Company."}],"balance_after":35000,"derivative":{"exercise_price":15.78,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001567619-22-002467","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860163/000156761922002467/doc1.xml","form_type":"4"}},{"id":2676010,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":130826,"kind":"person","name":"Zimmermann Carolyne","position":1,"cik":"0001860163","reported_name":"Zimmermann Carolyne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-09T20:28:24.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest with respect to 25% of the total number of the underlying shares on June 7, 2022, and the remaining shares will vest in equal monthly installments over the following three-year period, such that the stock option will be fully vested on June 7, 2025, subject to the Reporting Person continuing to be a service provider to Issuer through each vesting date."}],"balance_after":60000,"derivative":{"exercise_price":26.83,"expiration_date":"2031-06-06","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001567619-21-011946","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860163/000156761921011946/doc1.xml","form_type":"4"}}]}